Survey of Women's Choice of Delivery Before Consulting With Her Obstetrician

May 24, 2017 updated by: University of California, Davis

Understanding a Woman's Choice of Mode of Delivery Before Initial Consult With Her Obstetrician After Having One Prior Cesarean Section

We are surveying women who have had a previous cesarean section at the time of entry into prenatal care for their next pregnancy about their thoughts related to a trial of labor after cesarean (TOLAC) or repeat c-section.

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

This is a survey for women who have had a previous cesarean section, also known as a c-section, with their last pregnancy. The study is looking at what factors and people may influence the decisions women make about their birthing plan after they have had a previous c-section. If they qualify, women will be asked to complete a brief survey at their initial Ob/Gyn appointment before they see their Ob doctor. In order to qualify, women must:

  • Be pregnant
  • Have not seen an obstetrician for this pregnancy
  • Be at least 18 years old
  • Be able to read English
  • Have had a prior pregnancy delivered by c-section
  • Only had one prior c-section
  • The c-section must have been the last pregnancy before this one

Questions that will be asked include:

  • Demographic information (examples: age, race/ethnicity)
  • Pregnancy information
  • Delivery questions
  • Factors that may influence her birthing plan

Participants will also be asked if the study staff can follow up after her delivery to see what kind of delivery she had (vaginal or c-section).

Study Type

Observational

Enrollment (Actual)

8

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Sacramento, California, United States, 95817
        • University of California, Davis Department of Obstetrics and Gynecology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Participants will be selected from the new obstetrics patients in the University of California, Davis Department of Obstetrics and Gynecology department clinics.

Description

Inclusion Criteria:

  • Pregnant Women
  • 18 years old or older
  • Prior pregnancy with cesarean delivery
  • No prior obstetric physician care during current pregnancy

Exclusion Criteria:

  • More than one prior cesarean
  • Women who cannot read English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Women with a prior cesarean section
Survey of women who had a cesarean section with their last pregnancy and no other prior cesarean section deliveries
Survey

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant Opinions of mode of delivery as compared to actual mode of delivery
Time Frame: Mode of delivery will be assessed after delivery, average 40 weeks gestational age (7-9 months after enrollment)
Mode of delivery
Mode of delivery will be assessed after delivery, average 40 weeks gestational age (7-9 months after enrollment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Factors that influence participant's opinion of mode of delivery
Time Frame: Collected at time of study enrollment, typically 4-12 weeks into the subject's pregnancy.
Participants will be asked what influences their opinions of mode of delivery, such as significant other, clinicians, family, friends, or others. They will also be asked how much these factors may influence their decisions (high influence, some influence, no influence).
Collected at time of study enrollment, typically 4-12 weeks into the subject's pregnancy.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trust of information they receive
Time Frame: Collected at study enrollment, typically 4-12 weeks into the subject's pregnancy.
Participants will be asked if they trust the information that they receive from influencing factors, such as significant others, clinicians, family, friends, or other.
Collected at study enrollment, typically 4-12 weeks into the subject's pregnancy.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maricela Rangel-Garcia, University of California, Davis
  • Study Director: Mitchell Creinin, MD, University of California, Davis

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2013

Primary Completion (Actual)

April 1, 2015

Study Completion (Actual)

July 1, 2015

Study Registration Dates

First Submitted

September 27, 2013

First Submitted That Met QC Criteria

December 9, 2013

First Posted (Estimate)

December 13, 2013

Study Record Updates

Last Update Posted (Actual)

May 30, 2017

Last Update Submitted That Met QC Criteria

May 24, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 477211

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on Survey

3
Subscribe